These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 570217)
21. Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria. Ekstedt B Biochem Pharmacol; 1976 May; 25(10):1133-8. PubMed ID: 938537 [No Abstract] [Full Text] [Related]
22. Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase. Fowler CJ; Tipton KF Biochem Pharmacol; 1981 Dec; 30(24):3329-32. PubMed ID: 7326042 [No Abstract] [Full Text] [Related]
23. Characterization of N-methylphenylethylamine and N-methylphenylethanolamine as substrates for type A and type B monoamine oxidase. Suzuki O; Oya M; Katsumata Y Biochem Pharmacol; 1980 Oct; 29(19):2663-7. PubMed ID: 6775642 [No Abstract] [Full Text] [Related]
24. The reaction of bovine and rat liver monoamine oxidase with [14C]-clorgyline and [14C]-deprenyl. Salach JI; Detmer K; Youdim MB Mol Pharmacol; 1979 Jul; 16(1):234-41. PubMed ID: 481419 [No Abstract] [Full Text] [Related]
25. Substrate-selective activation of rat liver mitochondrial monoamine oxidase by oxygen. Fowler CJ; Callingham BA Biochem Pharmacol; 1978; 27(16):1995-2000. PubMed ID: 718722 [No Abstract] [Full Text] [Related]
26. Monoamine oxidase-III. Further studies of inhibition by propargylamines. Williams CH; Lawson J Biochem Pharmacol; 1975 Oct; 24(20):1889-91. PubMed ID: 1191339 [No Abstract] [Full Text] [Related]
27. The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes. Drukarch B; Flier J; Jongenelen CA; Andringa G; Schoffelmeer AN J Neural Transm (Vienna); 2006 May; 113(5):593-8. PubMed ID: 16252076 [TBL] [Abstract][Full Text] [Related]
28. Liver monoamine oxidase in the obese-hyperglycaemic (ob/ob) mouse. Tong JH; Limson-Zamora M; D'Iorio A; Bégin-Heick N Biochem J; 1979 Mar; 177(3):943-9. PubMed ID: 444212 [TBL] [Abstract][Full Text] [Related]
29. Oxidation of phenylethanolamine and octopamine by type A and type B monoamine oxidase. Effect of substrate concentration. Suzuki O; Katsumata Y; Oya M; Matsumoto T Biochem Pharmacol; 1979 Aug; 28(15):2327-32. PubMed ID: 387041 [No Abstract] [Full Text] [Related]
30. High proportions of type B monoamine oxidase in the discrete circumventricular regions of the rat. Kim JS; Hirano M; Uchimura H; Saito M; Matsumoto T; Nakahara T J Neurochem; 1979 Jan; 32(1):253-6. PubMed ID: 759580 [No Abstract] [Full Text] [Related]
31. Multiple catalytic sites of rat brain mitochondrial monoamine oxidase. Egashira T; Kuroiwa Y; Kamijo K Arch Biochem Biophys; 1978 Dec; 191(2):714-8. PubMed ID: 742896 [No Abstract] [Full Text] [Related]
32. The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain. Campbell IC; Robinson DS; Lovenberg W; Murphy DL J Neurochem; 1979 Jan; 32(1):49-55. PubMed ID: 32233 [No Abstract] [Full Text] [Related]
33. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria. Egashira T; Ekstedt B; Oreland L Biochem Pharmacol; 1976 Dec; 25(23):2583-6. PubMed ID: 985579 [No Abstract] [Full Text] [Related]
34. Substrate specificity and inhibitor sensitivity of monoamine oxidase in rat kidney mitochondria. Lyles GA; Shaffer CJ Biochem Pharmacol; 1979 Apr; 28(7):1099-106. PubMed ID: 444267 [No Abstract] [Full Text] [Related]
35. Phenylethylamine--deamination by multiple types of monoamine oxidase. Dial EJ; Clarke DE Biochem Pharmacol; 1978; 27(19):2374-5. PubMed ID: 728190 [No Abstract] [Full Text] [Related]
36. Comparison of monoamine oxidase in golden hamster islets and insulinoma. Feldman JM; Castleberry CA; Vervaert C; Seigler HF Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):307-20. PubMed ID: 6308735 [TBL] [Abstract][Full Text] [Related]
37. Monoamine oxidase activities in brown adipose tissue of the rat: some properties and subcellular distribution. Barrand MA; Callingham BA Biochem Pharmacol; 1982 Jun; 31(12):2177-84. PubMed ID: 7115437 [No Abstract] [Full Text] [Related]
38. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands. Lalies MD; Hibell A; Hudson AL; Nutt DJ Ann N Y Acad Sci; 1999 Jun; 881():114-7. PubMed ID: 10415906 [No Abstract] [Full Text] [Related]
39. Lipid substitution of mitochondrial monoamine oxidase can lead to the abolition of clorgyline selective inhibition without alteration in the A/B ratio assessed by substrate utilisation. Houslay MD Biochem Pharmacol; 1980 Dec; 29(23):3211-3. PubMed ID: 7447959 [No Abstract] [Full Text] [Related]
40. Studies on the subcellular localization of monoamine oxidase types A and B and its importance for the deamination of dopamine in the rat brain. Urwyler S; von Wartburg JP Biochem Pharmacol; 1980 Nov; 29(22):3067-73. PubMed ID: 6779822 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]